TF and neoplasm: DAB-LF and DAB-LFC therefore have the potential to deliver and express their carried DNA to remote tumors or metastases unsuitable for intratumoral treatments, but appear to be slightly less efficacious as DAB-Tf as tumor-targeting gene delivery systems.